PHARMA BIO CONSULT
ActiveFrom the official registers: KBO 7 annual accounts at the National Bank publications in the Belgian Official Gazette
Summary
PHARMA BIO CONSULT has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €34,629 and a net result of €156,029, of which €164,170 non-recurring income. Equity has been shrinking by about 12% per year since 2019. Its solvency ranks better than 25% of 2,559 sector peers (NACE 71, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Holdings and subsidiaries
1 holdingHoldings 1
-
6.7%
Connections & network
1 current directorThe board mandates are in the list below. The network lets you explore the same ties.